LM Funding Initiates Strategies to Monetize $165 Million of Unsecured Assets
Nov 09, 2016 21:15 pm UTC| Business
TAMPA, Fla., Nov. 09, 2016 -- LM Funding America, Inc. (NASDAQ:LMFA) (NASDAQ:LMFAW), a specialty finance company offering unique funding solutions to community associations, has initiated strategies to monetize $165...
Coupa Software to Report Third Quarter Fiscal 2017 Financial Results on December 5, 2016
Nov 09, 2016 21:15 pm UTC| Business
SAN MATEO, Calif., Nov. 09, 2016 -- Coupa Software (NASDAQ:COUP), a leader in cloud-based spend management, will report its financial results for its fiscal third quarter ended October 31, 2016, after market close on...
Mimecast Announces Second Quarter 2017 Financial Results
Nov 09, 2016 21:15 pm UTC| Business
Total revenue of $44.4 million grew 29% yoy on a GAAP basis and 38% in constant currencyAdded 1,900 new customers. Total customers 21,800 globallyRevenue retention rate of 111%Gross profit percentage of 72%GAAP EPS of...
HC2 Holdings Reports Third Quarter 2016 Results
Nov 09, 2016 21:12 pm UTC| Business
NEW YORK, Nov. 09, 2016 -- HC2 Holdings, Inc. (“HC2”) (NYSE MKT:HCHC), a diversified holding company that focuses on acquiring, operating and growing businesses that it considers to be under or fairly valued, today...
Lifeway Foods, Inc. Announces Results for the Third Quarter Ended September 30, 2016
Nov 09, 2016 21:11 pm UTC| Business
MORTON GROVE, Ill., Nov. 09, 2016 -- Lifeway Foods, Inc., (Nasdaq:LWAY), the leading U.S. supplier of kefir cultured dairy products, today reported financial results for the third quarter ended September 30, 2016. ...
Galena Biopharma Reports Third Quarter 2016 Financial Results and Provides a Corporate Update
Nov 09, 2016 21:10 pm UTC| Business
GALE-401 expected to initiate a Phase 3 clinical trial in Q2, 2017Top-Line results from NeuVax™ (nelipepimut-S) PRESENT Clinical TrialWebcast and conference call today at 2:00 p.m. P.T. / 5:00 p.m. E.T. SAN RAMON,...
KemPharm, Inc. Reports Third Quarter 2016 Results
Nov 09, 2016 21:10 pm UTC| Business
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 5:00 p.m., ET Recent Clinical Development Regulatory Highlights: Prioritized KP415 and KP201/IR as co-lead product...